Nadir Testosterone Within First Year of Androgen-Deprivation Therapy (ADT) Predicts for Time to Castration-Resistant Progression: A Secondary Analysis of the PR-7 Trial of Intermittent Versus Continuous ADT

Author Interview by ASCO

The JCO Exclusive Coverage series features interviews with authors
of recent
JCO and JOP Original Reports

JCO Exclusive Coverage is a new series of articles on ASCO.org that are designed to provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice. Based on interviews conducted with the lead or corresponding researchers behind JCO and JOP Original Reports, Exclusive Coverage articles convey the authors' thoughts on their study's key points and significance for clinical practice. The articles are written in an accessible style designed for quick reading.

Read the story: Testosterone Matters: Keeping Levels Low Among Men with Prostate Cancer Improves Survival